Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
NCT07756190
Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II StudyInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 2
NCT07756190Not Yet Recruiting
Phase 2
Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients W...Innovent Biologics (Suzho...
NCT07754565
Fatıgue Management and Qualıty of LıfeSaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07754565Completed
Not Applicable
Fatıgue Management and Qualıty of LıfeSaglik Bilimleri Universi...
NCT07754331
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinAstraZenecaNot Yet RecruitingPhase 1
NCT07754331Not Yet Recruiting
Phase 1
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolera...AstraZeneca
NCT07756463
Aquatic Versus Land-Based Exercise in Women With LipedemaCairo UniversityNot Yet RecruitingNot Applicable
NCT07756463Not Yet Recruiting
Not Applicable
Aquatic Versus Land-Based Exercise in Women With LipedemaCairo University
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese AdultsLumos PharmaNot Yet RecruitingPhase 2
NCT07754045Not Yet Recruiting
Phase 2
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutid...Lumos Pharma
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754227
Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Controlled TrialDr. Waseem UllahCompletedNot Applicable
NCT07754227Completed
Not Applicable
Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Con...Dr. Waseem Ullah
NCT07755865
A Clinical Trial to Evaluate the Effects of a Conditioning Mask on Hair Health, Breakage, Hydration, and DetanglingBounce CurlCompletedNot Applicable
NCT07755865Completed
Not Applicable
A Clinical Trial to Evaluate the Effects of a Conditioning Mask on Hair Health,...Bounce Curl
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07755917
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07755917Not Yet Recruiting
Not Applicable
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07755839
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro UniversityNot Yet RecruitingNot Applicable
NCT07755839Not Yet Recruiting
Not Applicable
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro University
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07754838
Acoustic Stimulation to Study and Modulate Sleepwalking and Related Arousal DisordersAnna CastelnovoNot Yet RecruitingNot Applicable
NCT07754838Not Yet Recruiting
Not Applicable
Acoustic Stimulation to Study and Modulate Sleepwalking and Related Arousal Diso...Anna Castelnovo
NCT07754123
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCJiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 3
NCT07754123Not Yet Recruiting
Phase 3
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patien...Jiangsu Hansoh Pharmaceut...
NCT07753824
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)Cancer Prevention Research Institute of TexasNot Yet RecruitingPhase 2
NCT07753824Not Yet Recruiting
Phase 2
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Pati...Cancer Prevention Researc...
NCT07756372
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions for Patients With a Progressive Collapsing Foot DeformityCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07756372Not Yet Recruiting
Not Applicable
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions fo...Canadian Institutes of He...
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07756047
Erector Spinae Plane vs Serratus Anterior Plane Catheter Infusions for Acute Pain Management in Patients With Traumatic Rib FracturesSunnybrook Health Sciences CentreNot Yet RecruitingNot Applicable
NCT07756047Not Yet Recruiting
Not Applicable
Erector Spinae Plane vs Serratus Anterior Plane Catheter Infusions for Acute Pai...Sunnybrook Health Science...
Result Breakdown
Not yet recruiting15 (75%)
Completed4 (20%)
Recruiting1 (5%)
not_applicable11 (55%)
Phase 24 (20%)
Phase 12 (10%)
Phase 41 (5%)
Not Specified1 (5%)
Phase 31 (5%)